Next |
home / stock / bio / bio message board
Subject | By | Source | When |
---|---|---|---|
Long and strong lets hope im right | SAE | investorshub | 05/02/2023 5:06:29 PM |
$BIO When is this gonna take off? | buhg1b | investorshub | 05/01/2023 2:34:39 AM |
$BIO Price gaining | SAE | investorshub | 04/30/2023 5:11:47 PM |
$BIO Price trading last up | PirateGary | investorshub | 04/30/2023 1:08:44 AM |
$BIO MomentumIts now | locksflooring | investorshub | 04/25/2023 2:33:56 AM |
$BIO The now | SAE | investorshub | 04/23/2023 11:53:45 PM |
$BIO Good read | SAE | investorshub | 04/23/2023 11:02:38 PM |
The gaining | Penny Roger$ | investorshub | 04/23/2023 4:16:48 AM |
got some short data | SAE | investorshub | 04/21/2023 3:32:28 AM |
MomentumIts trading last trade up | SAE | investorshub | 04/21/2023 2:46:14 AM |
we got news | SAE | investorshub | 04/19/2023 1:05:54 PM |
$BIO Good news recently, we should start to see this one move | SAE | investorshub | 04/14/2023 1:32:35 AM |
$BIO short squeeze | SAE | investorshub | 04/12/2023 9:54:19 AM |
we got news | SAE | investorshub | 04/12/2023 7:56:20 AM |
should we be shorting? | SAE | investorshub | 04/11/2023 9:55:21 AM |
best news of the day | SAE | investorshub | 04/09/2023 12:08:50 PM |
$BIO Price now last up | locksflooring | investorshub | 04/09/2023 2:03:28 AM |
The now | SAE | investorshub | 04/07/2023 4:31:30 PM |
whytestocks: $BIO News Article - Bio-Rad Presents Growth Strategy and Acceleration of Financial Targ | whytestocks | investorshangout | 02/25/2022 4:25:51 PM |
whytestocks: $BIO News Article - Bio-Rad Laboratories, inc (BIO) Q2 2021 Earnings Call Transcript | whytestocks | investorshangout | 07/30/2021 3:20:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will discuss these results in a conf...
- Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-Rad granted subsequent investment option upon FDA clearance IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Dr. Andrew Last, Executive Vice President and Chief Operating Officer, is planning to retire by early September of 2024. Dr. Last will remain part of ...